ImmunoGen, Inc. 3 SEC Filings

Filed On	Filing
19 Sep 2023	Form 3: White Lauren, SVP, CFO and PFO No securities owned
02 May 2023	Form 3: Kalofonos Isabel, SVP & CHIEF COMMERCIAL OFFICER No securities owned
03 Jan 2023	Form 3: Vasconcelles Michael, EVP R&D & MEDICAL AFFAIRS No securities owned
30 Nov 2022	Form 3: Char Daniel, SVP & CHIEF LEGAL OFFICER Holds 1,000 shares of Common Stock
17 Nov 2021	Form 3: Harrington-Smith Kristen, SVP & Chief Commercial Officer No securities owned
17 Nov 2021	Form 3: McCain Tracey L, Director No securities owned
23 Sep 2021	Form 3: Thackray Helen M., Director No securities owned
11 Jan 2021	Form 3: Lentini Renee, V.P.-Fin., Prin. Acctg. Off. Holds 12,148 shares of Common Stock
22 Jul 2020	Form 3: Altschuller Susan, SVP and CFO No securities owned
04 Jun 2020	Form 3: Coen Stacy Ann, Chief Business Officer No securities owned
20 Sep 2018	Form 3: Foster David G, V.P.-Fin., Prin. Acctg. Off. Holds 2,000 shares of Common Stock
26 Apr 2018	Form 3: McKee Blaine H., EVP & Chief Business Officer
24 Jan 2018	Form 3: Arbuckle Stuart A, Director
06 Apr 2017	Form 3: Ryll Thomas, VP, Technical Operations Holds 106,600 shares of Common Stock
16 Dec 2016	Form 3: Wingrove Theresa, VP of Regulatory Affairs
16 Dec 2016	Form 3: Berkenblit Anna, VP & Chief Medical Officer Holds 6,000 shares of Common Stock
19 May 2016	Form 3: Enyedy Mark J, Director Holds 75,100 shares of Common Stock
07 Jan 2015	Form 3: Gregory Richard J., Executive VP & CSO Holds 25,000 shares of Common Stock
22 Sep 2014	Form 3: Poole Sandra, Senior VP, Tech Operations
21 Feb 2014	Form 3: Harrison Ellie, VP & Chief HR Officer

Comments